Day: August 15, 2022

Consolidated revenue increased 5% over 2Q 2021 Announced strategic sale of Quest Integrity Business to Baker Hughes SUGAR LAND, Texas, Aug. 15, 2022 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global leading provider of integrated, digitally-enabled asset performance assurance and optimization solutions, today reported its financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Financial and Operational Results:Second quarter 2022 revenues were $251.3 million, an increase of 5.2% over the prior year quarter Gross margin was $70.0 million (27.8% of revenues), up $7.2 million from $62.8 million (26.3% of revenues) in Q2 2021 GAAP net loss was $21.6 million Consolidated Adjusted EBITDA was $14.3 million, up 57% as compared to $9.1 million in the 2021 period; and Announced strategic...

Trudhesa® TRx’s Grew 48% in Q2 2022 to Over 13K: Net Product Revenue Increased 59% Over Q1 2022 to $2.8 Million Sales Force Expanded by 50% to Capitalize on Prescription Momentum and Market Opportunity Company Reiterated Prescription Guidance Range of 70-85K TRx’s for 2022 Initiated Proof-of-Concept Study for INP105 in Autism Spectrum Disorder Impel to Host Investor Conference Call Today at 8:30 A.M. ET SEATTLE, Aug. 15, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update. “We continue to see robust growth and momentum with Trudhesa®, with a forty-eight percent increase...

Second quarter GAAP net income of $9.5 million, or $0.48 per diluted share Second quarter non-GAAP net loss of $3.6 million, or $(0.18) per diluted share During the quarter, Xcel sold a majority interest in its Isaac Mizrahi brand and entered into a joint venture and management agreement with the buyer, recognizing a gain of $20.6 million Approximately 65% of cash proceeds from the Isaac Mizrahi transaction used to pay off all outstanding debt, eliminating approximately $4.5 million of annual debt service expense Strengthened balance sheet with $10.9 million of cash and cash equivalents, no debt, and $16.7 million of working capital at June 30, 2022NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with significant expertise in livestream...

Dynacor is a dividend paying industrial gold ore processor headquartered in Montreal, Canada. The Corporation is engaged in the production of gold through the processing of ore purchased from the ASM (artisanal and small-scale mining) industry. Dynacor currently operates in Peru, where its management and processing teams have decades of experience working with ASM miners. It also owns a gold exploration property (Tumipampa) in the department of Apurimac.The Corporation also intends to expand its processing operations in other jurisdictions.Dynacor produces environmentally and socially responsible gold through its PX IMPACT® gold program. A growing number of supporting firms from the luxury fine jewelry, watchmaking and investment sectors pay a small premium to our client and strategic partner for this PX IMPACT® gold....

– Recently reported positive preliminary biomarker and safety data from ongoing Phase 1/2 clinical trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency – – Appointed Kurt Gunter, M.D. as senior vice president and chief medical officer – – Secured flexible debt facility for up to $70 million – – Cash, cash equivalents and investments as of quarter end, together with first tranche of debt facility, funds cash flow requirements into the second quarter of 2024 – BOSTON, Aug. 15, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today reported financial results for the second quarter ended June 30, 2022 and provided recent business highlights. “I am...

Highlighted by an 84% Growth in Amazon Sales Conference call will be held on August 15th at 11AM ET VANCOUVER, British Columbia, Aug. 15, 2022 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC (BABY) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, today reported second quarter 2022 financial results for the period ending June 30, 2022. The financial statements and MD&A are available on SEDAR under the Company’s profile. Second Quarter 2022 Financial HighlightsRevenues were $2.3M, a 44% increase versus $1.6M in 1Q22, driven by the expansion of the toddler products across all channels, and the introduction of the new Toddler Omega product. Sales on Amazon.com increased 84% sequentially versus 1Q22, an impressive acceleration from prior periods. Else...

GreenLight human health research labs GreenLight Biosciences Announces Second Quarter 2022 Financial Results and Highlights Recent Company ProgressGreenLight raised $108.4 million in private placement led by S2G Ventures with strong participation from existing and new investors with cash expected to fund critical programs through the first half of 2023.GreenLight and Samsung Biologics completed their first commercial-scale engineering run for mRNA COVID-19 vaccine.Human health partnerships include NIH to support COVID-19 vaccine development against emerging variants and a platform licensing agreement with Serum Institute of India (SII) to develop a vaccine for shingles and up to two other targets.Key milestones expected across plant health pipeline in 2022: anticipated EPA approval and launch of global-first foliar-applied RNA...